Lattice Biologics Ltd.

Lattice Biologics Ltd.verified

LBLTF

Price:

$0.0001

Market Cap:

$16.55K

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair i...[Read more]

Industry

Medical - Devices

IPO Date

2010-12-16

Stock Exchange

OTC

Ticker

LBLTF

The PE Ratio as of December 2025 (TTM) for Lattice Biologics Ltd. (LBLTF) is -0.01

According to Lattice Biologics Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.91% compared to the average of -10.81 of the last 4 quarters.

Lattice Biologics Ltd. (LBLTF) Historical PE Ratio (quarterly & annually)

How has LBLTF PE Ratio performed in the past?

The mean historical PE Ratio of Lattice Biologics Ltd. over the last ten years is -7.40. The current -0.01 PE Ratio has changed -86.48% with respect to the historical average. Over the past ten years (40 quarters), LBLTF's PE Ratio was at its highest in in the March 2019 quarter at 6.16. The PE Ratio was at its lowest in in the June 2021 quarter at -31.01.

Quarterly (TTM)
Annual

Average

-7.40

Median

-1.98

Minimum

-38.95

Maximum

-0.31

Lattice Biologics Ltd. (LBLTF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lattice Biologics Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 8.22%

Maximum Annual PE Ratio = -0.31

Minimum Annual Increase = -97.57%

Minimum Annual PE Ratio = -38.95

Quarterly (TTM)
Annual
YearPE RatioChange
2020-2.5653.11%
2019-1.67-22.72%
2018-2.16-48.93%
2017-4.23347.58%
2016-0.95-97.57%
2015-38.958.22%
2014-0.47-73.83%
2013-1.79-91.44%
2012-20.896.71%
2011-0.31-93.65%

Lattice Biologics Ltd. (LBLTF) Average PE Ratio

How has LBLTF PE Ratio performed in the past?

The current PE Ratio of Lattice Biologics Ltd. (LBLTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.13

5-year avg

-2.31

10-year avg

-7.40

Lattice Biologics Ltd. (LBLTF) PE Ratio vs. Peers

How is LBLTF’s PE Ratio compared to its peers?

Lattice Biologics Ltd.’s PE Ratio is greater than Verano Holdings Corp. (-0.93), less than CellaVision AB (publ) (24.61), greater than 4DMedical Limited (-31.67), less than PolyNovo Limited (63.00), greater than Euroapi S.A. (-2.30), less than Avon Technologies Plc (238.13), less than Beijing Tong Ren Tang Chinese Medicine Company Limited (14.72), less than Xvivo Perfusion AB (publ) (195.63), greater than World Financial Holding Group (-12118.56), greater than Allergy Therapeutics plc (-14.31),

Build a custom stock screener for Lattice Biologics Ltd. (LBLTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lattice Biologics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lattice Biologics Ltd. (LBLTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lattice Biologics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Lattice Biologics Ltd.'s PE Ratio?

How is the PE Ratio calculated for Lattice Biologics Ltd. (LBLTF)?

What is the highest PE Ratio for Lattice Biologics Ltd. (LBLTF)?

What is the 3-year average PE Ratio for Lattice Biologics Ltd. (LBLTF)?

What is the 5-year average PE Ratio for Lattice Biologics Ltd. (LBLTF)?

How does the current PE Ratio for Lattice Biologics Ltd. (LBLTF) compare to its historical average?